Stockreport

Signal or Noise: What VR Adviser's Spyre Theraputics Buy Means for Fools [Yahoo! Finance]

Spyre Therapeutics, Inc.  (SYRE) 
PDF Therapeutics (NASDAQ:SYRE) , an estimated $25.78 million trade based on quarterly average pricing. VR Adviser, LLC added 1,000,000 shares of Spyre Therapeutics; the es [Read more]